The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Canonical and Non-Canonical Aspects of JAK–STAT Signaling: Lessons from Interferons for Cytokine Responses
Open accessAbstract
Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signal transduction mediates cytokine responses. Canonical signaling is based on STAT tyrosine phosphorylation by activated JAKs. Downstream of interferon (IFN) receptors, activated JAKs cause the formation of the transcription factors IFN-stimulated gene factor 3 (ISGF3), a heterotrimer of STAT1, STAT2 and interferon regulatory factor 9 (IRF9) subunits, and gamma interferon-activated factor (GAF), a STAT1 homodimer. In recent years, several deviations from this paradigm were reported. These include kinase-independent JAK functions as well as extra- and intranuclear activities of U-STATs without phosphotyrosines. Additionally, transcriptional control by STAT complexes resembling neither GAF nor ISGF3 contributes to transcriptome changes in IFN-treated cells. Our review summarizes the contribution of non-canonical JAK-STAT signaling to the innate antimicrobial immunity imparted by IFN. Moreover, we touch upon functions of IFN pathway proteins beyond the IFN response. These include metabolic functions of IRF9 as well as the regulation of natural killer cell activity by kinase-dead TYK2 and different phosphorylation isoforms of STAT1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“The role of IRF proteins in adipocyte biology connects the immune response with metabolic regulation (150, 151).”
BackgroundInterferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., et al. (2010) · Nature Genetics · doi:10.1038/ng.717 · Cited by 2,520
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
Interferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,766
Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., & Stewart, T. A. (1993) · Science · doi:10.1126/science.8456300 · Cited by 1,727
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
O'Shea, J. J., Schwartz, D. M., Villarino, A. V., Gadina, M., McInnes, I. B., & Laurence, A. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051113-024537 · Cited by 1,599
Immune Response in Mice that Lack the Interferon-γ Receptor
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., & Aguet, M. (1993) · Science · doi:10.1126/science.8456301 · Cited by 1,548
Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors
Parganas, E., Wang, D., Stravopodis, D., Topham, D. J., Marine, J.-C., Teglund, S., Vanin, E. F., Bodner, S., Colamonici, O. R., van Deursen, J. M., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81167-8 · Cited by 1,156
Interferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154
Janus kinases in immune cell signaling
Ghoreschi, K., Laurence, A., & O’Shea, J. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00754.x · Cited by 1,149 · cited 1×
“Janus kinases are non-receptor tyrosine kinases which have essential roles in cytokine and growth factor signaling (40, 41).”
BackgroundTHE IFNγ RECEPTOR:A Paradigm for Cytokine Receptor Signaling
Bach, E. A., Aguet, M., & Schreiber, R. D. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.563 · Cited by 1,034
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
Collaborative Association Study of Psoriasis (CASP), Tsoi, L. C., Genetic Analysis of Psoriasis Consortium, Psoriasis Association Genetics Extension, Wellcome Trust Case Control Consortium 2, Spain, S. L., Knight, J., Ellinghaus, E., Stuart, P. E., Capon, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2467 · Cited by 1,024
Function of Mitochondrial Stat3 in Cellular Respiration
Wegrzyn, J., Potla, R., Chwae, Y.-J., Sepuri, N. B. V., Zhang, Q., Koeck, T., Derecka, M., Szczepanek, K., Szelag, M., Gornicka, A., et al. (2009) · Science · doi:10.1126/science.1164551 · Cited by 1,014
Aicardi–Goutières syndrome and the type I interferonopathies
Crow, Y. J., & Manel, N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3850 · Cited by 925 · cited 1×
“On the other hand, their proinflammatory activity renders them driving forces behind a group of interferonopathies, such as the AicardiGoutieres syndrome (12, 13).”
BackgroundJak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis
Neubauer, H., Cumano, A., Müller, M., Wu, H., Huffstadt, U., & Pfeffer, K. (1998) · Cell · doi:10.1016/s0092-8674(00)81168-x · Cited by 914
Self-citationA protein tyrosine kinase in the interferon αβ signaling pathway
Velazquez, L., Fellous, M., Stark, G. R., & Pellegrini, S. (1992) · Cell · doi:10.1016/0092-8674(92)90105-l · Cited by 872
Type I interferon: friend or foe?
Trinchieri, G. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 844
A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
Lacronique, V., Boureux, A., Della Valle, V., Poirel, H., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997) · Science · doi:10.1126/science.278.5341.1309 · Cited by 791
Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation
Gough, D. J., Corlett, A., Schlessinger, K., Wegrzyn, J., Larner, A. C., & Levy, D. E. (2009) · Science · doi:10.1126/science.1171721 · Cited by 716
Minegishi, Y., Saito, M., Morio, T., Watanabe, K., Agematsu, K., Tsuchiya, S., Takada, H., Hara, T., Kawamura, N., Ariga, T., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.009 · Cited by 702
Interferons α and β as Immune Regulators—A New Look
Biron, C. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00154-6 · Cited by 667
Yang, J., Liao, X., Agarwal, M. K., Barnes, L., Auron, P. E., & Stark, G. R. (2007) · Genes & Development · doi:10.1101/gad.1553707 · Cited by 611
Sigurdsson, S., Nordmark, G., Göring, H. H. H., Lindroos, K., Wiman, A.-C., Sturfelt, G., Jönsen, A., Rantapää-Dahlqvist, S., Möller, B., Kere, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/428480 · Cited by 607
Isaacs, A., & Lindenmann, J. (2015) · The Journal of Immunology · doi:10.1093/jimmunol/195.5.1911 · Cited by 602
Interferon-inducible effector mechanisms in cell-autonomous immunity
MacMicking, J. D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3210 · Cited by 579
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype
Toubiana, J., Okada, S., Hiller, J., Oleastro, M., Lagos Gomez, M., Aldave Becerra, J. C., Ouachée-Chardin, M., Fouyssac, F., Girisha, K. M., Etzioni, A., et al. (2016) · Blood · doi:10.1182/blood-2015-11-679902 · Cited by 577
Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation
Zhang, X., Bogunovic, D., Payelle-Brogard, B., Francois-Newton, V., Speer, S. D., Yuan, C., Volpi, S., Li, Z., Sanal, O., Mansouri, D., et al. (2015) · Nature · doi:10.1038/nature13801 · Cited by 558
Defective TNF-α-Induced Apoptosis in STAT1-Null Cells Due to Low Constitutive Levels of Caspases
Kumar, A., Commane, M., Flickinger, T. W., Horvath, C. M., & Stark, G. R. (1997) · Science · doi:10.1126/science.278.5343.1630 · Cited by 514
Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.
Brinkmann, V, Geiger, T., Alkan, S., & Heusser, C. H. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1655 · Cited by 506
T-bet: a bridge between innate and adaptive immunity
Lazarevic, V., Glimcher, L. H., & Lord, G. M. (2013) · Nature Reviews Immunology · doi:10.1038/nri3536 · Cited by 486 · cited 1×
“In the adaptive immunity, IFNγ plays an important role in Th1 responses, repressing the development of Th2 and Th17 T cell responses (30) and acting directly on B cells to promote class switching from IgG2 to IgG3 (32).”
BackgroundConstitutive Type I Interferon Modulates Homeostatic Balance through Tonic Signaling
Gough, D. J., Messina, N. L., Clarke, C. J. P., Johnstone, R. W., & Levy, D. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.011 · Cited by 470
The Yin and Yang of type I interferon activity in bacterial infection
Decker, T., Müller, M., & Stockinger, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1684 · Cited by 468
Self-citationRodero, M. P., & Crow, Y. J. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20161596 · Cited by 433
Interferon-Lambda: A New Addition to an Old Family
Donnelly, R. P., & Kotenko, S. V. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0078 · Cited by 420
Partial Impairment of Cytokine Responses in Tyk2-Deficient Mice
Karaghiosoff, M., Neubauer, H., Lassnig, C., Kovarik, P., Schindler, H., Pircher, H., McCoy, B., Bogdan, C., Decker, T., Brem, G., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00054-6 · Cited by 420
Self-citationImmune Response in Stat2 Knockout Mice
Park, C., Li, S., Cha, E., & Schindler, C. (2000) · Immunity · doi:10.1016/s1074-7613(00)00077-7 · Cited by 415
Reich, N. C., & Liu, L. (2006) · Nature Reviews Immunology · doi:10.1038/nri1885 · Cited by 376
Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor.
Decker, T., Lew, D. J., Mirkovitch, J., & Darnell, J. E. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08026.x · Cited by 374
Self-citationHuman TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome
Kreins, A. Y., Ciancanelli, M. J., Okada, S., Kong, X.-F., Ramírez-Alejo, N., Kilic, S. S., El Baghdadi, J., Nonoyama, S., Mahdaviani, S. A., Ailal, F., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140280 · Cited by 363
Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells
Mancuso, G., Gambuzza, M., Midiri, A., Biondo, C., Papasergi, S., Akira, S., Teti, G., & Beninati, C. (2009) · Nature Immunology · doi:10.1038/ni.1733 · Cited by 351
New Mouse Model for Dengue Virus Vaccine Testing
Johnson, A. J., & Roehrig, J. T. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.783-786.1999 · Cited by 350
Chatterjee-Kishore, M., Wright, K. L., Ting, J. P.-Y., & Stark, G. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.4111 · Cited by 346
Biologic consequences of Stat1-independent IFN signaling
Gil, M. P., Bohn, E., O'Guin, A. K., Ramana, C. V., Levine, B., Stark, G. R., Virgin, H. W., & Schreiber, R. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111163898 · Cited by 344
Parsing the interferon transcriptional network and its disease associations
Mostafavi, S., Yoshida, H., Moodley, D., LeBoité, H., Rothamel, K., Raj, T., Ye, C. J., Chevrier, N., Zhang, S.-Y., Feng, T., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.032 · Cited by 337
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
Cheon, H., Holvey-Bates, E. G., Schoggins, J. W., Forster, S., Hertzog, P., Imanaka, N., Rice, C. M., Jackson, M. W., Junk, D. J., & Stark, G. R. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.203 · Cited by 334
The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes
Wallace, C., Smyth, D. J., Maisuria-Armer, M., Walker, N. M., Todd, J. A., & Clayton, D. G. (2010) · Nature Genetics · doi:10.1038/ng.493 · Cited by 325
Henry, T., Brotcke, A., Weiss, D. S., Thompson, L. J., & Monack, D. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062665 · Cited by 323
Inborn Errors of Human JAKs and STATs
Casanova, J.-L., Holland, S. M., & Notarangelo, L. D. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.016 · Cited by 320
Shimoda, K., Kato, K., Aoki, K., Matsuda, T., Miyamoto, A., Shibamori, M., Yamashita, M., Numata, A., Takase, K., Kobayashi, S., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00055-8 · Cited by 319
Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes
Cheon, H., & Stark, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903487106 · Cited by 305
Bancerek, J., Poss, Z. C., Steinparzer, I., Sedlyarov, V., Pfaffenwimmer, T., Mikulic, I., Dölken, L., Strobl, B., Müller, M., Taatjes, D. J., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.017 · Cited by 297
Self-citationHuang, L. J.-S., Constantinescu, S. N., & Lodish, H. F. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00401-4 · Cited by 294
Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn Disease
Wang, K., Zhang, H., Kugathasan, S., Annese, V., Bradfield, J. P., Russell, R. K., Sleiman, P. M. A., Imielinski, M., Glessner, J., Hou, C., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.01.026 · Cited by 291
Boisson-Dupuis, S., Kong, X.-F., Okada, S., Cypowyj, S., Puel, A., Abel, L., & Casanova, J.-L. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.04.011 · Cited by 287
Varinou, L., Ramsauer, K., Karaghiosoff, M., Kolbe, T., Pfeffer, K., Müller, M., & Decker, T. (2003) · Immunity · doi:10.1016/s1074-7613(03)00322-4 · Cited by 284
Self-citationThe regulation of inflammation by interferons and their STATs
Rauch, I., Müller, M., & Decker, T. (2013) · JAK-STAT · doi:10.4161/jkst.23820 · Cited by 281
Self-citationThe human model: a genetic dissection of immunity to infection in natural conditions
Casanova, J.-L., & Abel, L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1264 · Cited by 277
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis
The UK Primary Biliary Cirrhosis (PBC) Consortium, Liu, J. Z., The Wellcome Trust Case Control Consortium 3, Almarri, M. A., Gaffney, D. J., Mells, G. F., Jostins, L., Cordell, H. J., Ducker, S. J., Day, D. B., et al. (2012) · Nature Genetics · doi:10.1038/ng.2395 · Cited by 274
Kovarik, P., Stoiber, D., Eyers, P. A., Menghini, R., Neininger, A., Gaestel, M., Cohen, P., & Decker, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13956 · Cited by 273
Self-citationCrotta, S., Davidson, S., Mahlakoiv, T., Desmet, C. J., Buckwalter, M. R., Albert, M. L., Staeheli, P., & Wack, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003773 · Cited by 269
IL-28 and IL-29: Newcomers to the interferon family
Uzé, G., & Monneron, D. (2007) · Biochimie · doi:10.1016/j.biochi.2007.01.008 · Cited by 260
Type I IFN Signaling Is Crucial for Host Resistance against Different Species of Pathogenic Bacteria
Mancuso, G., Midiri, A., Biondo, C., Beninati, C., Zummo, S., Galbo, R., Tomasello, F., Gambuzza, M., Macrì, G., Ruggeri, A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3126 · Cited by 251
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression
Ragimbeau, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg038 · Cited by 215
Hahm, B., Trifilo, M. J., Zuniga, E. I., & Oldstone, M. B. A. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.005 · Cited by 210
Gauzzi, M. C., Velazquez, L., McKendry, R., Mogensen, K. E., Fellous, M., & Pellegrini, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20494 · Cited by 187
Early cellular responses to Salmonella infection: dendritic cells, monocytes, and more
Tam, M. A., Rydström, A., Sundquist, M., & Wick, M. J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00679.x · Cited by 184
Majumder, S., Zhou, L. Z.-H., Chaturvedi, P., Babcock, G., Aras, S., & Ransohoff, R. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4736 · Cited by 184
SUMO Modification of STAT1 and Its Role in PIAS-mediated Inhibition of Gene Activation
Rogers, R. S., Horvath, C. M., & Matunis, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301344200 · Cited by 174
Marg, A., Shan, Y., Meyer, T., Meissner, T., Brandenburg, M., & Vinkemeier, U. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403057 · Cited by 173
Majumder, S., Zhou, L., Chaturvedi, P., Babcock, G., Aras, S., & Ransohoff, R. M. (1998) · PubMed · Cited by 171
The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses
Błaszczyk, K., Nowicka, H., Kostyrko, K., Antonczyk, A., Wesoły, J., & Bluyssen, H. A. R. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.02.010 · Cited by 170
Wang, X.-A., Zhang, R., She, Z.-G., Zhang, X.-F., Jiang, D.-S., Wang, T., Gao, L., Deng, W., Zhang, S.-M., Zhu, L.-H., et al. (2014) · Hepatology · doi:10.1002/hep.26751 · Cited by 159
Production of Type I IFN Sensitizes Macrophages to Cell Death Induced by Listeria monocytogenes
Stockinger, S., Materna, T., Stoiber, D., Bayr, L., Steinborn, R., Kolbe, T., Unger, H., Chakraborty, T., Levy, D. E., Müller, M. M., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6522 · Cited by 159
Self-citationPIAS proteins promote SUMO-1 conjugation to STAT1
Ungureanu, D., Vanhatupa, S., Kotaja, N., Yang, J., Aittomäki, S., Jänne, O. A., Palvimo, J. J., & Silvennoinen, O. (2003) · Blood · doi:10.1182/blood-2002-12-3816 · Cited by 158
TEL-JAK2 transgenic mice develop T-cell leukemia
Carron, C., Cormier, F., Janin, A., Penard‐Lacronique, V., Giovannini, M., Daniel, M., Bernard, O., & Ghysdael, J. (2000) · Blood · doi:10.1182/blood.v95.12.3891.012k13_3891_3899 · Cited by 155
Drosophila STAT is required for directly maintaining HP1 localization and heterochromatin stability
Shi, S., Larson, K., Guo, D., Lim, S. J., Dutta, P., Yan, S., & Li, W. X. (2008) · Nature Cell Biology · doi:10.1038/ncb1713 · Cited by 153
Bluyssen, H. R., & Levy, D. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4600 · Cited by 150
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-γ signaling and antiviral responses
Zimmermann, A., Trilling, M., Wagner, M., Wilborn, M., Bubić, I., Jonjić, S., Koszinowski, U. H., & Hengel, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041401 · Cited by 150
Perry, S. T., Buck, M. D., Lada, S. M., Schindler, C., & Shresta, S. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001297 · Cited by 144
CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance
Putz, E. M., Gotthardt, D., Hoermann, G., Csiszar, A., Wirth, S., Berger, A., Straka, E., Rigler, D., Wallner, B., Jamieson, A. M., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.012 · Cited by 143
Self-citationBluyssen, H. A. R., Muzaffar, R., Vlieststra, R. J., van der Made, A. C., Leung, S., Stark, G. R., Kerr, I. M., Trapman, J., & Levy, D. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5645 · Cited by 142
Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor
Ban, M., Goris, A., Lorentzen, Å. R., Baker, A., Mihalova, T., Ingram, G., Booth, D. R., Heard, R. N., Stewart, G. J., Bogaert, E., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.41 · Cited by 138
Fink, K., & Grandvaux, N. (2013) · JAK-STAT · doi:10.4161/jkst.27521 · Cited by 137
Interferon Regulatory Factors Are Transcriptional Regulators of Adipogenesis
Eguchi, J., Yan, Q.-W., Schones, D. E., Kamal, M., Hsu, C.-H., Zhang, M. Q., Crawford, G. E., & Rosen, E. D. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.002 · Cited by 133
Shresta, S., Sharar, K. L., Prigozhin, D. M., Snider, H. M., Beatty, P. R., & Harris, E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3946 · Cited by 133
Martinez-Moczygemba, M., Gutch, M. J., French, D. L., & Reich, N. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20070 · Cited by 132
Multiple sclerosis susceptibility alleles in African Americans
Johnson, B. A., Wang, J., Taylor, E. M., Caillier, S. J., Herbert, J., Khan, O. A., Cross, A. H., Jager, P. L. D., Gourraud, P., Cree, B., et al. (2009) · Genes and Immunity · doi:10.1038/gene.2009.81 · Cited by 131
Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells
Penard‐Lacronique, V., Boureux, A., Monni, R., Dumon, S., Mauchauffé, M., Mayeux, P., Gouilleux, F., Berger, R., Gisselbrecht, S., Ghysdael, J., et al. (2000) · Blood · doi:10.1182/blood.v95.6.2076 · Cited by 130
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility
Couturier, N., Bucciarelli, F., Nurtdinov, R., Debouverie, M., Lebrun‐Frénay, C., Defer, G. L., Moreau, T., Confavreux, C., Vukusic, S., Cournu‐Rebeix, I., et al. (2011) · Brain · doi:10.1093/brain/awr010 · Cited by 127
Ramsauer, K., Farlik, M., Zupkovitz, G., Seiser, C., Kröger, A., Häuser, H., & Decker, T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610944104 · Cited by 124
Self-citationFreudenberg, M. A., Merlin, T., Kalis, C., Chvatchko, Y., STÜBIG, H., & Galanos, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1665 · Cited by 121
Tyrosine kinase 2 (TYK2) in cytokine signalling and host immunity
Strobl, B. (2011) · Frontiers in bioscience · doi:10.2741/3908 · Cited by 115
Multi-tasking: nuclear transcription factors with novel roles in the mitochondria
Szczepanek, K., Lesnefsky, E. J., & Larner, A. C. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.05.001 · Cited by 114
Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance
Wang, X., Zhang, R., Zhang, S., Deng, S., Jiang, D., Zhong, J., Yang, L. C., Wang, T., Hong, S., Guo, S., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00505.2012 · Cited by 113
Kraus, T., Lau, J. F., Parisien, J.-P., & Horvath, C. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212972200 · Cited by 112
Activation of the Transcription Factor ISGF3 by Interferon-gamma
Matsumoto, M., Tanaka, N., Harada, H., Kimura, T., Yokochi, T., Kitagawa, M., Schindler, C., & Taniguchi, T. (1999) · Biological Chemistry · doi:10.1515/bc.1999.087 · Cited by 111
Shahni, R., Cale, C. M., Anderson, G. W., Osellame, L. D., Hambleton, S., Jacques, T. S., Wedatilake, Y., Taanman, J., Chan, E., Qasim, W., et al. (2015) · Brain · doi:10.1093/brain/awv182 · Cited by 111
Tough, D. F., Zhang, X. M., & Sprent, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6007 · Cited by 107
STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling
Begitt, A., Droescher, M., Meyer, T., Schmid, C. D., Baker, M., Antunes, F., Knobeloch, K., Owen, M. R., Naumann, R., Decker, T., et al. (2014) · Nature Immunology · doi:10.1038/ni.2794 · Cited by 104
Self-citationJiang, D., Liu, Y., Zhou, H., Zhang, Y., Zhang, X.-D., Zhang, X.-F., Chen, K., Gao, L., Peng, J., Gong, H., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02653 · Cited by 100
Castiglia, V., Piersigilli, A., Ebner, F., Janos, M., Goldmann, O., Damböck, U., Kröger, A., Weiss, S., Knapp, S., Jamieson, A. M., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.02.003 · Cited by 100
Self-citationInterferons Direct an Effective Innate Response to Legionella pneumophila Infection
Plumlee, C. R., Lee, C., Beg, A. A., Decker, T., Shuman, H. A., & Schindler, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018283 · Cited by 99
Self-citationSTAT1-Independent Cell Type-Specific Regulation of Antiviral APOBEC3G by IFN-α
Sarkis, P. T. N., Ying, S., Xu, R., & Yu, X.-F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4530 · Cited by 96
Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth
Hu, X., Dutta, P., Tsurumi, A., Li, J., Wang, J., Land, H., & Li, W. X. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221243110 · Cited by 95
Cell Type-Specific and Tyrosine Phosphorylation-Independent Nuclear Presence of STAT1 and STAT3
Meyer, T., Gavénis, K., & Vinkemeier, U. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5405 · Cited by 95
Tyk2 and Stat3 Regulate Brown Adipose Tissue Differentiation and Obesity
Derecka, M., Górnicka, A., Koralov, S. B., Szczepanek, K., Morgan, M., Raje, V., Sisler, J. D., Zhang, Q., Otero, D. C., Cichy, J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.005 · Cited by 95
Wang, X.-A., Zhang, R., Jiang, D., Deng, W., Zhang, S., Deng, S., Zhong, J., Wang, T., Zhu, L.-H., Yang, L. C., et al. (2013) · Hepatology · doi:10.1002/hep.26368 · Cited by 93
Interferon Regulatory Factor 9 Protects Against Cardiac Hypertrophy by Targeting Myocardin
Jiang, D., Luo, Y., Zhang, R., Zhang, X.-D., Chen, H., Zhang, Y., Chen, K., Zhang, S., Fan, G., Liu, P. P., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02083 · Cited by 91
Fatal combined immunodeficiency associated with heterozygous mutation in STAT1
Sharfe, N., Nahum, A., Newell, A., Dadi, H., Ngan, B., Pereira, S. L., Herbrick, J.-A., & Roifman, C. M. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.032 · Cited by 85
Park, H. J., Li, J., Hannah, R., Biddie, S. C., Leal-Cervantes, A. I., Kirschner, K., Cruz, D. F. S., Sexl, V., Göttgens, B., & Green, A. R. (2015) · The EMBO Journal · doi:10.15252/embj.201592383 · Cited by 84
Two Rare Disease-Associated Tyk2 Variants Are Catalytically Impaired but Signaling Competent
Li, Z., Gakovic, M., Ragimbeau, J., Eloranta, M., Rönnblom, L., Michel, F., & Pellegrini, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203118 · Cited by 81
SUMO conjugation of STAT1 protects cells from hyperresponsiveness to IFNγ
Begitt, A., Droescher, M., Knobeloch, K., & Vinkemeier, U. (2011) · Blood · doi:10.1182/blood-2011-04-347930 · Cited by 80
Interferon regulatory factor 9 is critical for neointima formation following vascular injury
Zhang, S., Zhu, L., Chen, H., Zhang, R., Zhang, P., Jiang, D.-S., Gao, L., Tian, S., Wang, L., Zhang, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms6160 · Cited by 80
Hellquist, A., Järvinen, T. M., Koskenmies, S., Zucchelli, M., Orsmark‐Pietras, C., Berglind, L., Panelius, J., Hasan, T., Julkunen, H. A., D’Amato, M., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081160 · Cited by 80
Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells.
Luker, K. E., Pica, C. M., Schreiber, R. D., & Piwnica-Worms, D. R. (2001) · PubMed · Cited by 79
TYK2 Kinase Activity Is Required for Functional Type I Interferon Responses In Vivo
Prchal‐Murphy, M., Semper, C., Lassnig, C., Wallner, B., Gausterer, C., Ingeborg, T., Kobolák, J., Müller, S., Kolbe, T., Karaghiosoff, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039141 · Cited by 76
Self-citationSato, K., Shiota, M., Fukuda, S., Iwamoto, E., Machida, H., Inamine, T., Kondo, S., Yanagihara, K., Isomoto, H., Mizuta, Y., et al. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9320-x · Cited by 76
Boisson, B., Quartier, P., & Casanova, J. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.01.005 · Cited by 75
Morrow, A., Schmeisser, H., Tsuno, T., & Zoon, K. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001359 · Cited by 74
Lou, Y., Pan, X., Jia, P.-M., Li, D., Shu Dong, X. I. A. O., Zhang, Z., Chen, S., Zhu, C. H., & Tong, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4922 · Cited by 73
Rani, M. R. S., Leaman, D. W., Han, Y., Leung, S., Croze, E., Fish, E. N., Wolfman, A., & Ransohoff, R. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32507 · Cited by 72
A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis
Mero, I., Lorentzen, Å. R., Ban, M., Smestad, C., Celius, E. G., Aarseth, J. H., Myhr, K., Link, J., Hillert, J. A., Olsson, T. P., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.195 · Cited by 71
Fink, K., Martin, L., Mukawera, E., Chartier, S., Deken, X. D., Brochiero, E., Miot, F., & Grandvaux, N. (2013) · Cell Research · doi:10.1038/cr.2013.47 · Cited by 71
Association of polymorphisms across the tyrosine kinase gene, TYK2 in UK SLE families
Graham, D. S. C., Akil, M., & Vyse, T. J. (2007) · Rheumatology · doi:10.1093/rheumatology/kel449 · Cited by 71
Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy
Lü, J., Bian, Z., Zhang, R., Zhang, Y., Liu, C., Yan, L., Zhang, S.-M., Jiang, D.-S., Wei, X., Zhu, X. H., et al. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-012-0326-9 · Cited by 71
Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons
Rauch, I., Rosebrock, F., Hainzl, E., Heider, S., Majoros, A., Wienerroither, S., Strobl, B., Stockinger, S., Kenner, L., Müller, M. M., et al. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01498-14 · Cited by 71
Self-citationHo, J., Pelzel, C., Begitt, A., Mee, M., Elsheikha, H. M., Scott, D. J., & Vinkemeier, U. (2016) · PLoS Biology · doi:10.1371/journal.pbio.2000117 · Cited by 68
A Critical Role for Interferon Regulatory Factor 9 in Cerebral Ischemic Stroke
Chen, H., Guo, S., Li, Z.-Z., Lu, Y., Jiang, D.-S., Zhang, R., Lei, H. C., Gao, L., Zhang, X., Zhang, Y., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1545-14.2014 · Cited by 67
Exome sequencing identifies a novel multiple sclerosis susceptibility variant in the TYK2 gene
Dyment, D. A., Cader, M. Z., Chao, M. J., Lincoln, M. R., Morrison, K., Disanto, G., Morahan, J. M., DeLuca, G. C., Sadovnick, A. D., Lepage, P., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182616fc4 · Cited by 66
Early IFN type I response: Learning from microbial evasion strategies
Coccia, E. M., & Battistini, A. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.005 · Cited by 64
Cui, X., Zhang, L., Luo, J., Rajasekaran, A., Hazra, S., Cacalano, N. A., & Dubinett, S. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210222 · Cited by 63
Lee, J. E., Yang, Y., Liang, F., Gough, D. J., Levy, D. E., & Sehgal, P. B. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00379.2011 · Cited by 62
Majoros, A., Platanitis, E., Szappanos, D., Cheon, H., Vogl, C., Shukla, P., Stark, G. R., Sexl, V., Schreiber, R. D., Schindler, C., et al. (2016) · EMBO Reports · doi:10.15252/embr.201540726 · Cited by 60
Self-citationDroescher, M., Begitt, A., Marg, A., Zacharias, M., & Vinkemeier, U. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.235978 · Cited by 59
Kumar, K. G., Varghese, B., Banerjee, A., Baker, D. P., Constantinescu, S. N., Pellegrini, S., & Fuchs, S. Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800991200 · Cited by 56
George, C. X., Das, S., & Samuel, C. E. (2008) · Virology · doi:10.1016/j.virol.2008.07.029 · Cited by 56
Song, L., Bhattacharya, S., Yunus, A. A., Lima, C. D., & Schindler, C. (2006) · Blood · doi:10.1182/blood-2006-04-020271 · Cited by 56
Buß, C., Opitz, B., Hocke, A. C., Lippmann, J., van Laak, V., Hippenstiel, S., Krüll, M., Suttorp, N., & Eitel, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902947 · Cited by 49
Unphosphorylated STATs go nuclear
Brown, S., & Zeidler, M. P. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.09.002 · Cited by 47
The emerging role of interferon regulatory factor 9 in the antiviral host response and beyond
Suprunenko, T., & Hofer, M. J. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.03.002 · Cited by 47
Sisler, J. D., Morgan, M., Raje, V., Grande, R. C., Derecka, M., Meier, J. A., Cantwell, M. T., Szczepanek, K., Korzun, W. J., Lesnefsky, E. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144444 · Cited by 46
Potla, R., Koeck, T., Węgrzyn, J., Cherukuri, S., Shimoda, K., Baker, D. P., Wolfman, J. C., Planchon, S. M., Esposito, C., Hoit, B. D., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00497-06 · Cited by 44
Bourke, L., Knight, R. A., Latchman, D. S., Stephanou, A., & McCormick, J. (2013) · JAK-STAT · doi:10.4161/jkst.25666 · Cited by 41
Suarez-Gestal, M., Pérez-Pampín, E. M., Calaza, M., Gómez-Reino, J. J., & Gonzalez, A. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2990 · Cited by 40
IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9
Erb, H. H. H., Langlechner, R. V., Moser, P. L., Handle, F., Casneuf, T., Verstraeten, K., Schlick, B., Schäfer, G., Hall, B. M., Sasser, K., et al. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0222 · Cited by 37
Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs
Sater, A. A. A., Majoros, A., Plumlee, C. R., Perry, S. T., Gu, A.-D., Lee, C., Shresta, S., Decker, T., & Schindler, C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401139 · Cited by 36
Self-citationSTAT signaling in Dictyostelium development
Kawata, T. (2011) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2010.01243.x · Cited by 34
Sehgal, P. B. (2013) · JAK-STAT · doi:10.4161/jkst.24860 · Cited by 31
Induction of β-R1/I-TAC by Interferon-β Requires Catalytically Active TYK2
Rani, M. R. S., Gauzzi, M. C., Pellegrini, S., Fish, E. N., Wei, T., & Ransohoff, R. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.1891 · Cited by 30
Peluso, C., Christofolini, D. M., Goldman, C., Mafra, F., Cavalcanti, V., Barbosa, C. P., & Bianco, B. A. V. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.09.007 · Cited by 25
Vogl, C., Flatt, T., Fuhrmann, B., Hofmann, E., Wallner, B., Stiefvater, R., Kovarik, P., Strobl, B., & Müller, M. M. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-199 · Cited by 23
Self-citationKeil, E., Finkenstädt, D., Wufka, C., Trilling, M., Liebfried, P., Strobl, B., Müller, M. M., & Pfeffer, K. (2013) · Blood · doi:10.1182/blood-2013-03-492157 · Cited by 21
Self-citationNovel non-canonical role of STAT1 in Natural Killer cell cytotoxicity
Putz, E. M., Majoros, A., Gotthardt, D., Prchal‐Murphy, M., Zebedin-Brandl, E. M., Fux, D. A., Schlattl, A., Schreiber, R. D., Carotta, S., Müller, M. M., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1186314 · Cited by 18
Self-citationDecker, T. (2016) · The EMBO Journal · doi:10.15252/embj.201693974 · Cited by 13
Self-citation
Cited by
IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy
Ivashkiv, L. B. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0029-z · Cited by 1,358
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Dhatchinamoorthy, K., Colbert, J. D., & Rock, K. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.636568 · Cited by 1,077
The JAK-STAT pathway at 30: Much learned, much more to do
Philips, R. L., Wang, Y., Cheon, H., Kanno, Y., Gadina, M., Sartorelli, V., Horvath, C. M., Darnell, J. E., Stark, G. R., & O’Shea, J. J. (2022) · Cell · doi:10.1016/j.cell.2022.09.023 · Cited by 720
Tumor-Infiltrating Natural Killer Cells
Cózar, B., Greppi, M., Carpentier, S., Narni-Mancinelli, E., Chiossone, L., & Vivier, E. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0655 · Cited by 476
Metadata
- Authors
- Majoros, A., Platanitis, E., Kernbauer-Hölzl, E., Rosebrock, F., Müller, M., & Decker, T.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-01-26
- Volume
- 8
- Pages
- 29-29
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2580811839
- Cited by
- 325
- References
- 161
- FWCI
- 11.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.